A report by Lennard-Jones estimated that in the United Kingdom, the incidence of short-bowel syndrome requiring such therapy was two patients per million population. Byrne et al estimated that in the United States, approximately 10,000-20,000 patients receive home-delivered TPN for short-bowel syndrome.(Dec,2017)